Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.
The updated Teradyne model now points to a higher assessed fair value, rising from US$374.82 to US$416.65, an 11% move that has sharpened attention on where analysts see the stock settling. That shift sits alongside commentary highlighting heavier focus on semiconductor capital spending, AI infrastructure, and long term addressable market forecasts, with bulls and bears debating how Teradyne’s backlog quality and execution might justify or challenge these higher targets. As you read on, you will see how to track this evolving narrative and what signals to watch next.
Stay updated as the Fair Value for Teradyne shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Teradyne.
What Wall Street Has Been Saying 🐂 Bullish Takeaways
Teradyne has seen a series of sizeable price target increases, with Cantor Fitzgerald, Susquehanna, BofA and Baird all lifting targets, in some cases into the US$525 to US$550 range. This signals that recent model updates are feeding into higher assessed upside.
Susquehanna cites channel checks that point to an SCE backlog extending beyond one year and characterizes WFE expectations as high as US$300b, which feeds into higher estimates for 2026 and 2027 and new 2028 projections.
Cantor Fitzgerald links its US$550 target to expectations that AI infrastructure buildout could help drive semiconductor industry revenue toward roughly US$3t by calendar 2029 and potentially above US$3.5t by 2030. In its view, this supports Teradyne’s longer term growth runway.
BofA’s move to a US$525 target follows an update to its broader semiconductor models, with the firm now using a 2030 total industry addressable market forecast of US$2.7t, tied to memory, data center, auto and industrial demand. These are all areas where Teradyne’s test exposure is seen as relevant.
🐻 Bearish Takeaways
The concentration of recent research around raised targets and larger industry forecasts leaves limited published discussion of risks. This may prompt some investors to question execution against a growing backlog, the timing of WFE spending, and how much optimism is already reflected in Teradyne’s valuation.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives!
NasdaqGS:TER 1-Year Stock Price Chart
We’ve flagged 1 risk for Teradyne. See which could impact your investment.
Story Continues
How This Changes the Fair Value For Teradyne
Fair value for Teradyne has moved from US$374.82 to US$416.65, an increase of about 11% based on the updated model.
The long term revenue growth assumption has shifted from 21.28% to 22.90% in the Teradyne framework.
The modeled profit margin has adjusted slightly from 29.99% to 29.90% for Teradyne.
The future P/E multiple applied to Teradyne has moved from 37.68x to 40.49x.
The discount rate used for Teradyne has changed from 10.98% to 11.09%.
Never Miss an Update: Follow The Narrative
Narratives link Teradyne’s business story to a set of financial assumptions and a fair value, updating as new data, guidance, and news arrive. They help you see how product moves, acquisitions, and macro risks feed into the numbers analysts are using.
Head over to the Simply Wall St Community and follow the Narrative on Teradyne to stay up to date on:
How Teradyne is positioning around AI accelerators, robotics, semiconductor automation, and new production board test opportunities for AI compute and mobile.
The expected impact of the Quantifi Photonics acquisition, the structural reorganization in robotics, and the planned share buyback of up to US$1b through 2026.
Key risks including tariffs and trade policy uncertainty, weaker robotics revenue, and how product mix shifts could affect gross margins and earnings volatility.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include TER.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com